Analyst Price Targets — ATHA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 19, 2025 11:02 am | Graig Suvannavejh | Mizuho Securities | $4.00 | $3.83 | TheFly | Athira Pharma price target lowered to $4 from $5 at Mizuho |
| June 22, 2022 6:52 pm | Andrew Tsai | Jefferies | $3.00 | $2.85 | TheFly | Athira Pharma downgraded to Hold from Buy at Jefferies |
| April 21, 2022 8:46 am | — | Berenberg Bank | $33.00 | $11.63 | Benzinga | Berenberg Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $33 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ATHA

White Rock, British Columbia--(Newsfile Corp. - April 13, 2026) - Athena Gold Corporation (CSE: ATHA) (OTCQB: AHNRD) ("Athena" or the "Company") is pleased to announce it has been awarded CAD $200,000 in non-dilutive grant funding from the Ontario government through the Ontario Junior Exploration Program ("OJEP"). Administered by the Ontario Ministry of Mines, the OJEP grant provides financial assistance to junior…

HIGHLIGHTS Ongoing site mobilization commenced in mid-March - including fuel, supplies, & equipment inclusive of delivery of a third diamond drill, supplied by Base Diamond Drilling Ltd. - in support of the 2026 Exploration Program at the Angilak Uranium Project; Mobilization is being completed via ATR planes (Photo 1 & 2) departing from Yellowknife, Northwest Territories, and Baker Lake and Rankin Inlet, Nunavut,…

Tightening share structure ahead of fully-funded, maiden drill program in Red Lake WHITE ROCK, BC / ACCESS Newswire / March 27, 2026 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena" or the "Company") announces that its Board of Directors has approved a consolidation of the Company's issued and outstanding common shares on the basis of every nine point nine (9.9) pre-consolidation common shares for every…

InflaRx (NASDAQ: IFRX - Get Free Report) and Athira Pharma (NASDAQ: ATHA - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Risk and Volatility InflaRx has a beta of

Drilling returns 1.25 g/t Au over 33.54m; Buster Trend further expanded WHITE ROCK, BC / ACCESS Newswire / March 19, 2026 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena" or the "Company") is pleased to provide an exploration update from its Excelsior Springs Project in Nevada. Mammoth Minerals Limited (ASX: M79) (formerly Firetail Resources Limited) has been aggressively exploring Excelsior, per its…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ATHA.
Senate Trading
No Senate trades found for ATHA.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
